Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
Clinical trial NCT06563388 · RECRUITING
Trial details
- NCT number
- NCT06563388
- Sponsor
- Roswell Park Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-18
- Primary completion
- 2032-09-18
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.